Glutathione S-transferase alpha 1 risk polymorphism and increased bilateral thalamus mean diffusivity in schizophrenia

Psychiatry Research - Neuroimaging

Volumn 203, Issue 2-3, 2012, Pages 180-183

  Spalletta, Gianfranco ^a   Piras, Fabrizio ^a   Gravina, Paolo ^b   Bello, Mario Lo ^b   Bernardini, Sergio ^b   Caltagirone, Carlo ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Auditory hallucination; Diffusion tensor imaging; Neuroimaging; Oxidative stress

Indexed keywords

GLUTATHIONE TRANSFERASE ALPHA;

ADULT; ALLELE; ARTICLE; AUDITORY HALLUCINATION; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAY MATTER; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OXIDATIVE STRESS; POSITIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; THALAMUS;

ADULT; ALLELES; DIFFUSION MAGNETIC RESONANCE IMAGING; DOMINANCE, CEREBRAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HALLUCINATIONS; HETEROZYGOTE DETECTION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THALAMUS;

EID: 84867141591     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.12.016     Document Type: Article

References (36)

1. Adriano F., Spoletini I., Caltagirone C., Spalletta G. Updated meta-analyses reveal thalamus volume reduction in patients with first-episode and chronic schizophrenia. Schizophrenia Research 2010, 123:1-14.
2. Agarwal N., Rambaldelli G., Perlini C., Dusi N., Kitis O., Bellani M., Cerini R., Isola M., Versace A., Balestrieri M., Gasparini A., Mucelli R.P., Tansella M., Brambilla P. Microstructural thalamic changes in schizophrenia: a combined anatomic and diffusion weighted magnetic resonance imaging study. Journal of Psychiatry & Neuroscience 2008, 33:440-448.
3. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nature Medicine 2004, 10:S18-S25. Suppl.
4. Andreasen N.C. Scale for the Assessment of Negative Symptoms 1981, University of Iowa College of Medicine, Iowa City, IA.
5. Andreasen N.C. Scale for the Assessment of Positive Symptoms 1984, University of Iowa College of Medicine, Iowa City, IA.
6. Andreasen N.C., Paradiso S., O'Leary D.S. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?. Schizophrenia Bulletin 1998, 24:203-218.
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Press, Washington, DC, Text Revision. Fourth Edition.
8. Behrendt R.P., Young C. Hallucinations in schizophrenia, sensory impairment, and brain disease: a unifying model. Behavioral and Brain Science 2004, 27:771-787.
9. Byne W., Hazlett E.A., Buchsbaum M.S., Kemether E. The thalamus and schizophrenia: current status of research. Acta Neuropathologica 2009, 117:347-368.
10. Coles B.F., Morel F., Rauch C., Huber W.W., Yang M., Teitel C.H., Green B., Lang N.P., Kadlubar F.F. Effect of polymorphism in the human glutathione S-transferase A1 (hGSTA1) promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001, 11:663-669.
11. Cronenwett W.J., Csernansky J. Thalamic pathology in schizophrenia. Current Topics in Behavioral Neurosciences 2010, 4:509-528.
12. Dean O.M., van den Buuse M., Bush A.I., Copolov D.L., Ng F., Dodd S., Berk M. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Current Medicinal Chemistry 2009, 16:2965-2976.
13. Deichmann R., Schwarzbauer C., Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3T. NeuroImage 2004, 21:757-767.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
15. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
16. Gaziev J., Nguyen L., Puozzo C., Mozzi A.F., Casella M., Perrone Donnorso M., Gravina P., Sodani P., Marziali M., Isgrò A., Simone M.D., Andreani M., Formosa A., Testi M., Federici G., Bernardini S., Lucarelli G. Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring. Blood 2010, 115:4597-4604.
17. Gravina P., Spoletini I., Masini S., Valentini A., Vanni D., Paladini E., Bossù P., Caltagirone C., Federici G., Spalletta G., Bernardini S. Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophrenia. Psychiatry Research 2011, 187:454-456.
18. Hayes J.D., Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61:154-166.
19. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annual Reviews of Pharmacological Toxicology 2005, 45:51-88.
20. Jones D.P. Radical-free biology of oxidative stress. American Journal of Physiology. Cell Physiology 2008, 295:C849-C868.
21. Kantarci K., Senjem M.L., Avula R., Zhang B., Samikoglu A.R., Weigand S.D., Przybelski S.A., Edmonson H.A., Vemuri P., Knopman D.S., Boeve B.F., Ivnik R.J., Smith G.E., Petersen R.C., Jack C.R. Diffusion tensor imaging and cognitive function in older adults with no dementia. Neurology 2011, 77:26-34.
22. Kreczmanski P., Heinsen H., Mantua V., Woltersdorf F., Masson T., Ulfig N., Schmidt-Kastner R., Korr H., Steinbusch H.W., Hof P.R., Schmitz C. Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain 2007, 130:678-692.
23. Le Bihan D. The wet mind. Physics in Medicine and Biology 2007, 52:R52-R57.
24. Morel F., Rauch C., Coles B., Le Ferrec E., Guillouzo A. The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter. Pharmacogenetics 2002, 12:277-286.
25. Oquendo M.A., Baca-Garcia E., Kartachov A., Khait V., Campbell C.E., Richards M., Sackeim H.A., Prudic J., Mann J.J. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. The Journal of Clinical Psychiatry 2003, 64:825-833.
26. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Archives of General Psychiatry 1990, 47:1023-1028.
27. Popken G.J., Bunney W.E., Potkin S.G., Jones E.G. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proceeding of the National Academy of Sciences USA 2000, 97:9276-9280.
28. Radonjic N.V., Knezevic I.D., Vilimanovich U., Kravic-Stevovic T., Marina L.V., Nikolic T., Todorovic V., Bumbasirevic V., Petronijevic N.D. Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration. Neuropharmacology 2010, 58:739-745.
29. Ruesch N., Spoletini I., Wilke M., Bria P., Di Paola M., Di Iulio F., Martinotti G., Caltagirone C., Spalletta G. Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophrenia Research 2007, 93:78-89.
30. Spoletini I., Cherubini A., Banfi G., Rubino I.A., Peran P., Caltagirone C., Spalletta G. Hippocampi, thalami, and accumbens microstructural damage in schizophrenia: a volumetry, diffusivity, and neuropsychological study. Schizophrenia Bulletin 2011, 37:118-130.
31. Sykova E. Extrasynaptic volume transmission and diffusion parameters of the extracellular space. Neuroscience 2004, 129:861-876.
32. Sykova E., Nicholson C. Diffusion in brain extracellular space. Physiological Reviews 2008, 88:1277-1340.
33. Valentini A., Gravina P., Bernardini S., Federici G. Role of glutathione S-transferase in the cellular antioxidant defence. Enzymes and the Cellular Fight Against Oxidation 2008, Research Signpost. A.M. Eleuteri (Ed.).
34. Wood S.J., Yucel M., Pantelis C., Berk M. Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Annals of the Academy of Medicine, Singapore 2009, 38:396-401.
35. Young K.A., Manaye K.F., Liang C., Hicks P.B., German D.C. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biological Psychiatry 2000, 47:944-953.
36. Zhang D., Zhu M., Humphreys W.G. Drug Metabolism in Drug Design and Development 2007, John Wiley & Sons, Hoboken, NJ.